Dataset opportunity
Impulse Dynamics — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Impulse Dynamics, usable for Diagnostic AI and Computer Vision.
Score
67.8
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global artificial intelligence in diagnostics market = $2.0 billion in 2025, CAGR 21.7%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Impulse Dynamics holds a proprietary Medical Imaging Dataset derived from its Class III medical devices, integrating image data with `iot_data` telemetry and `medical_records`. This provides a uniquely comprehensive collection for training and validating Diagnostic AI algorithms, linking imaging directly to device performance and long-term patient health information (PHI).
The global AI in diagnostics market is a significant and rapidly expanding sector, valued at USD 2.0 billion in 2025 with a projected CAGR of 21.7%. Despite complex access requiring strict HIPAA/GDPR compliance and adherence to clinical trial data protocols, the rarity and longitudinal nature of this outcomes-based data offer a distinct competitive advantage for buyers in this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Data involves highly sensitive Class III medical device telemetry and patient health information (PHI).; Access requires strict HIPAA/GDPR compliance and likely clinical trial data sharing protocols.; Ownership of long-term outcomes data is tied to multi-year clinical study registries. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Impulse Dynamics owns a unique, multi-modal dataset linking formal clinical study outcomes in heart failure patients to proprietary, device-generated physiological data. This high-rarity asset is ideal for diagnostic AI companies seeking to develop and validate predictive models for cardiac care, a key segment within the rapidly expanding $2.0 billion artificial intelligence in diagnostics market. The presence of established data protection frameworks demonstrates a clear and compliant path to commercialization, significantly increasing the dataset's strategic value.
See dimension details ↓- Dataset Specificity78
dominant 'medical_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
Demand from Diagnostic AI buyers is extremely high, driven by a market projected to grow at a 21.7% CAGR from its 2025 valuation of $2.0 billion.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation73
3 data-appetite signals (3 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Impulse Dynamics is a good target as it's an SME that manufactures and sells a proprietary medical device, the Optimizer® system, which generates a significant amount of clinical and device performance data as a by-product of its core business, and there is no evidence they currently sell this data. Issues: The company is privately held and venture-backed, having raised significant funding rounds, which might affect its data strategy long-term. [5, 13, 21]; While they don't appear to sell data now, the data collected for clinical trials (like INTEGRA-D and AIM HIGHer) is extensive and could be a future monetization
- Deep Qualification90
⚠ needs review — Impulse Dynamics is a medical device manufacturer, not a data seller, whose core product is an implantable device for heart failure therapy. While it holds valuable longitudinal data from device telemetry and extensive clinical trials, the 'Medical Imaging' label is unsubstantiated. Data access is highly restricted by medical privacy regulations (PHI), clinical trial protocols, and patient consent, making commercial resale of the raw data unlikely. [licensing restricted; dataset_type implausible vs real activity: The company's device, the Optimizer system, delivers electrical pulses (Cardiac Contractility Modulation) and senses the heart's electrical activity; it is not an imaging device and there is no evidence it collects medical imaging data. [9, 16]]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
The company holds structured data from formal clinical studies (FIX-HF-5, FIX-HF-12) on heart failure, providing critical patient outcomes like ejection fraction that are essential for training and validating diagnostic AI models.
IoT / sensor data
Impulse Dynamics generates proprietary time-series data from its Optimizer Smart System, offering a rare, longitudinal view of patient cardiac response that is highly sought after for developing predictive therapy-monitoring algorithms.
business_records
The existence of formal data protection statements indicates a compliant process for handling patient information, significantly de-risking the data for commercial AI development and future regulatory submissions.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Impulse Dynamics Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global artificial intelligence in diagnostics market = $2.0 billion in 2025, CAGR 21.7% (source: Grand View Research).. Investment score 67.8/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Codeomedical — Maintenance Logs Dataset Opportunity
View opportunity →healthcareMediproma — Maintenance Logs Dataset Opportunity
View opportunity →healthcarePrimed Halberstadt — Industrial Operations Dataset Opportunity
View opportunity →